135 related articles for article (PubMed ID: 29738696)
1. Serum human epididymis secretory protein 4 as a potential biomarker of renal fibrosis in kidney transplantation recipients.
Luo J; Wang F; Wan J; Ye Z; Huang C; Cai Y; Liu M; Wu BQ; Li L
Clin Chim Acta; 2018 Aug; 483():216-221. PubMed ID: 29738696
[TBL] [Abstract][Full Text] [Related]
2. Elevated serum concentrations of HE4 as a novel biomarker of disease severity and renal fibrosis in kidney disease.
Wan J; Wang Y; Cai G; Liang J; Yue C; Wang F; Song J; Wang J; Liu M; Luo J; Li L
Oncotarget; 2016 Oct; 7(42):67748-67759. PubMed ID: 27589683
[TBL] [Abstract][Full Text] [Related]
3. Urinary Human Epididymis Secretory Protein 4 as a Useful Biomarker for Subclinical Acute Rejection Three Months after Kidney Transplantation.
Tajima S; Fu R; Shigematsu T; Noguchi H; Kaku K; Tsuchimoto A; Okabe Y; Masuda S
Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31546745
[TBL] [Abstract][Full Text] [Related]
4. Serum human epididymis protein 4 concentrations are associated with severity of patients with pulmonary tuberculosis.
Li L; Yao Y; Liang J; Zhan X; Wang F; Yue C; Wu BQ; Hu S; Liu M; Wan J; Luo J
Clin Chim Acta; 2020 Mar; 502():255-260. PubMed ID: 31730821
[TBL] [Abstract][Full Text] [Related]
5. Human Epididymis Protein 4: A Novel Serum Inflammatory Biomarker in Cystic Fibrosis.
Nagy B; Nagy B; Fila L; Clarke LA; Gönczy F; Bede O; Nagy D; Újhelyi R; Szabó Á; Anghelyi A; Major M; Bene Z; Fejes Z; Antal-Szalmás P; Bhattoa HP; Balla G; Kappelmayer J; Amaral MD; Macek M; Balogh I
Chest; 2016 Sep; 150(3):661-72. PubMed ID: 27105680
[TBL] [Abstract][Full Text] [Related]
6. Potential association between elevated serum human epididymis protein 4 and renal fibrosis: A systemic review and meta-analysis.
Chen P; Yang Q; Li X; Qin Y
Medicine (Baltimore); 2017 Sep; 96(36):e7824. PubMed ID: 28885334
[TBL] [Abstract][Full Text] [Related]
7. Human epididymis protein 4 concentration is not associated with liver fibrosis and cirrhosis in a case control study.
Zhang M; Yuan L; Yao F; Cao P; Rong J; Zhang B; Su J
Clin Chim Acta; 2018 Sep; 484():213-217. PubMed ID: 29864404
[TBL] [Abstract][Full Text] [Related]
8. Elevated serum HE4 levels as a novel biomarker of disease severity and hepatic fibrosis in autoimmune hepatitis.
Yu Z; Nian C; Sun W; Liu X; Nian X
Clin Chim Acta; 2024 Jun; 559():119682. PubMed ID: 38643819
[TBL] [Abstract][Full Text] [Related]
9. Human Epididymis Protein 4 as a Potential Biomarker of Chronic Kidney Disease in Female Patients With Normal Ovarian Function.
Yuan T; Li Y
Lab Med; 2017 Aug; 48(3):238-243. PubMed ID: 28934517
[TBL] [Abstract][Full Text] [Related]
10. HE4 Serum Levels Are Associated with Heart Failure Severity in Patients With Chronic Heart Failure.
Piek A; Meijers WC; Schroten NF; Gansevoort RT; de Boer RA; Silljé HH
J Card Fail; 2017 Jan; 23(1):12-19. PubMed ID: 27224553
[TBL] [Abstract][Full Text] [Related]
11. Cell-free microRNA-148a is associated with renal allograft dysfunction: Implication for biomarker discovery.
Nariman-Saleh-Fam Z; Bastami M; Ardalan M; Sharifi S; Hosseinian Khatib SM; Zununi Vahed S
J Cell Biochem; 2019 Apr; 120(4):5737-5746. PubMed ID: 30320905
[TBL] [Abstract][Full Text] [Related]
12. Elevated human epididymis protein 4 concentrations in chronic kidney disease.
Nagy B; Krasznai ZT; Balla H; Csobán M; Antal-Szalmás P; Hernádi Z; Kappelmayer J
Ann Clin Biochem; 2012 Jul; 49(Pt 4):377-80. PubMed ID: 22688735
[TBL] [Abstract][Full Text] [Related]
13. Clinical and pathological analyses of interstitial fibrosis and tubular atrophy cases after kidney transplantation.
Shimizu T; Toma H; Hayakawa N; Shibahara R; Ishiyama R; Hayashida A; Fujimori D; Tsunoyama K; Ikezawa E; Kitajima S; Iida S; Ishida H; Tanabe K; Honda K; Koike J
Nephrology (Carlton); 2016 Jul; 21 Suppl 1():26-30. PubMed ID: 26972969
[TBL] [Abstract][Full Text] [Related]
14. Cystatin C provides a better estimate of the effect of glomerular filtration rate on serum human epididymis protein 4 concentrations.
Ferraro S; Pasqualetti S; Carnevale A; Panteghini M
Clin Chem Lab Med; 2016 Oct; 54(10):1629-34. PubMed ID: 27092650
[TBL] [Abstract][Full Text] [Related]
15. Circulating miR-150, miR-192, miR-200b, and miR-423-3p as Non-invasive Biomarkers of Chronic Allograft Dysfunction.
Zununi Vahed S; Poursadegh Zonouzi A; Mahmoodpoor F; Samadi N; Ardalan M; Omidi Y
Arch Med Res; 2017 Jan; 48(1):96-104. PubMed ID: 28577875
[TBL] [Abstract][Full Text] [Related]
16. Clinical significance of serum human epididymis protein 4 in liver fibrosis: An experimental study.
Hou Y; Li F; Chen J; Zhao J; Li D; Chen H
Medicine (Baltimore); 2020 Nov; 99(48):e23428. PubMed ID: 33235124
[TBL] [Abstract][Full Text] [Related]
17. Circulating donor-specific anti-HLA antibodies are a major factor in premature and accelerated allograft fibrosis.
Gosset C; Viglietti D; Rabant M; Vérine J; Aubert O; Glotz D; Legendre C; Taupin JL; Duong Van-Huyen JP; Loupy A; Lefaucheur C
Kidney Int; 2017 Sep; 92(3):729-742. PubMed ID: 28554738
[TBL] [Abstract][Full Text] [Related]
18. Determination of the Upper Reference Limit of Human Epididymis Secretory Protein 4 (HE4) in Healthy Male Individuals and Correlation with Renal and Fertility Markers.
Schirinzi A; Cazzolla AP; Mascolo E; Palmieri G; Pesce F; Gesualdo L; Santacroce L; Ballini A; Lovero R; Di Serio F
Endocr Metab Immune Disord Drug Targets; 2021; 21(5):912-918. PubMed ID: 32767951
[TBL] [Abstract][Full Text] [Related]
19. Single Nucleotide Polymorphisms of IL-33 Gene Correlated with Renal Allograft Fibrosis in Kidney Transplant Recipients.
Liu X; Liu K; Gui Z; Feng D; Wang Z; Zheng M; Fei S; Chen H; Sun L; Han Z; Ju X; Zhang H; Tan R; Gu M
J Immunol Res; 2021; 2021():8029180. PubMed ID: 34950738
[TBL] [Abstract][Full Text] [Related]
20. Serum Human Epididymis Protein 4 is a Potential Biomarker for Early Chronic Kidney Disease in an Obese Population.
Tan S; Zeng Y; Kuang S; Li J
Diabetes Metab Syndr Obes; 2021; 14():1601-1608. PubMed ID: 33889001
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
